ArticleCancers2020

Progression-Free Survival and Overall Survival in Patients with Advanced HER2-Positive Breast Cancer Treated with Trastuzumab Emtansine (T-DM1) after Previous Treatment with Pertuzumab.

Laura L Michel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.